Mydecine Innovations Group announces a share consolidation of 1 post-consolidation share for every 50 pre-consolidation shares.
Delic Holdings announces receiving a Health Canada 56 Research Exemption to conduct research on various psychedelic drugs.
Awakn Life Sciences reports that it now has three clinics in operation, including its new flagship clinic in London.
In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues.
Magic mushroom's drug psilocybin can lead to long-term improvements in depression symptom severity, a small study has found.
Red Light Holland announces the purchase of 100 acres of farmland in Ontario that it is targeting for mushroom cultivation.
Red Light Holland's new Chief Marketing Officer, Ridley Doolittle, has extensive experience in brand development, including a senior position with Bacardi.
Cybin announces the publication bu WIPO of Cybin's patent application for psychedelics-based delivery systems.
Red Light Holland announces it is participating in a Harvard-sponsored online webinar on psychedelic drug law policy.
Awakn Life Sciences announces the completion of its "hit to lead" program on developing new chemical entities (NCE).